We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Enveda Biosciences Stock

Invest in or calculate the value of your shares in Enveda Biosciences or other pre-IPO companies through EquityZen's platform.

Get Started

Enveda Biosciences Stock (ENVB)

Enveda Biosciences is a biotechnology company engineering new drugs from plants.

About Enveda Biosciences Stock

Founded

2019

Headquarters

Boulder, CO, US

Industries

Software, Artificial Intelligence, Data and Analytics

Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologies systematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration. Enveda, launched in 2019, is headquartered in Boulder, Colorado.

Enveda Biosciences Management

Leadership team at Enveda Biosciences

Founder & CEO

Viswa Colluru

Board Member

Pegah Ebrahimi

Locked Features

Join now and verify your accreditation status to gain access to:

  • Enveda Biosciences current valuation
  • Enveda Biosciences stock price
  • Available deals in Enveda Biosciences and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Enveda Biosciences Stock

How to invest in Enveda Biosciences stock?

Accredited investors can buy pre-IPO stock in companies like Enveda Biosciences through EquityZen funds. These investments are made available by existing Enveda Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Enveda Biosciences stock?

Shareholders can sell their Enveda Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."